Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Royalty Pharma Sub-manager, Llc > Profile

Instuitional Investor - Royalty Pharma Sub-manager, Llc

Fund Profile
Filing Period:
Fund Name: Royalty Pharma Sub-manager, Llc
Portfolio Value $196,268,588
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Cytokinetics Inc
 CYTK 980,392 $64,617,637 32.92%
2.
Zenas Biopharma Inc.
 ZBIO 2,388,150 $64,408,406 32.82%
3.
Biohaven Ltd.
 BHVN 2,936,507 $39,202,368 19.97%
4.
Kailera Therapeutics
 2,455,357 $28,040,177 14.29%
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.